US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist
  • 4.0400
  • +0.1600+4.12%
Close Nov 4 16:00 ET
  • 4.2600
  • +0.2200+5.45%
Post 18:21 ET
37.29MMarket Cap-655P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q2
Stock NameRevenueRatio
Single segment263.14K100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States2.24M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.26%